Field safety notices: NeuMoDx Molecular Inc.
Manufacturer registered in EUDAMED: SRN US-MF-000009823 ; country: United States
2 authority publications by one authority, from 14 Jun 2021 to 5 Mar 2024.
Latest notice: 5 Mar 2024, ANSM, Réactif NeuMoDx HIV-1 Quant Assay
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by NeuMoDx Molecular Inc. or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
2 distinct corrective actions.
- Réactif NeuMoDx HIV-1 Quant Assay
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Consommable NeuMoDx Cartridge utilisé avec les réactifs NeuMoDx SARS-CoV-2 ou NeuMoDx Flu A-B/RSV/SARS-CoV-2 sur automates NeuMoDx 288 ou NeuMoDx 96 Molecular Systems
Source : ANSM, informations de sécurité · collected 16 Nov 2026